These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4951907)

  • 41. [Liposomes as vehicles of antitubercular drugs - a new appraoch to experimental chemotherapy of tuberculosis].
    Vladimirskiĭ MA; Strel'tsov VP; Stapanov VM; Braude VI
    Probl Tuberk; 1980 Jul; (7):53-6. PubMed ID: 7413638
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effect of vitamin B6 on the blood isoniazid concentration and its role in the regulation of the functional state of central nervous system in dogs].
    Bondarev IM; Tregubov IuG; Klebanova AA
    Probl Tuberk; 1974; 65(4):73-7. PubMed ID: 4835661
    [No Abstract]   [Full Text] [Related]  

  • 43. [Chemotherapy in combination with the rapid intravenous administration of isoniazid in pulmonary tuberculosis].
    Zbants AN; Tsurkan VP; Mustiatsé NA; Kurochkin SIa; Ustiian AI
    Probl Tuberk; 1982 Dec; (12):45-8. PubMed ID: 7156122
    [No Abstract]   [Full Text] [Related]  

  • 44. [The morphological reactions in the lungs during the chemotherapy of experimental tuberculosis].
    Erokhin VV
    Probl Tuberk; 2000; (5):15-9. PubMed ID: 11077845
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Isoniazid-H3 distribution in a tubercular focus in the wall of a pulmonary cavern in rats].
    Cherednichenko LP
    Probl Tuberk; 1969; 47(5):80-5. PubMed ID: 5367976
    [No Abstract]   [Full Text] [Related]  

  • 46. [Evaluation of the efficiency of activity of the liposomal form of isoniazid against different types of mycobacteria in vitro].
    Golyshevskaia VI; Selishcheva AA; Martynova LP; Lepekha LN; Kalashnikova TM; Kornilova ZKh; Erokhin VV; Rozenberg OA
    Probl Tuberk Bolezn Legk; 2006; (8):61-4. PubMed ID: 17002062
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Liver function in patients with pulmonary tuberculosis receiving maximal toeerable doses of isoniazid].
    Voskresenskiĭ ON; Gavrilenko VS; Iqnatova AV; Semenova VN; Starostenko EV
    Probl Tuberk; 1977; (2):31-5. PubMed ID: 866308
    [No Abstract]   [Full Text] [Related]  

  • 48. [Intramuscular administration of a 10% isoniazid solution-- a new method of controlled chemotherapy].
    Shesterina MV; Sagalovich VIa; Tarasova EF; Vilenskaia RN; Kireeva SG
    Probl Tuberk; 1987; (10):27-31. PubMed ID: 3422948
    [No Abstract]   [Full Text] [Related]  

  • 49. [Healing of destructive pulmonary tuberculosis depending on bacteriostatic effect of various methods of treatment].
    Sokolova GB; Galenko NN; Kanevskaia SS
    Probl Tuberk; 1978 Nov; (11):30-5. PubMed ID: 103090
    [No Abstract]   [Full Text] [Related]  

  • 50. [Pharmacokinetics of isoniazid in patients with pulmonary tuberculosis].
    Protsiuk RG; Petrenko VI
    Sov Med; 1985; (3):94-8. PubMed ID: 4023845
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effectiveness and possibilities of application to ambulatory patients in our region of a pulmonary tuberculosis therapy by the intermittent administration (I.V.) of the triple association isoniazid-streptomycin-PAS (preliminary results after a year)].
    Burghard G; Petitjean R; Schranz J; Scherrer B
    Rev Tuberc Pneumol (Paris); 1970; 34(3):439-53. PubMed ID: 5515514
    [No Abstract]   [Full Text] [Related]  

  • 52. [Treatment of patients with destructive pulmonary tuberculosis using intramuscular isoniazid administration].
    Panasiuk AV; Il'nitskiĭ IG; Kunichkina SA; Azarenko II; Lola AT
    Vrach Delo; 1988 Aug; (8):69-71. PubMed ID: 3206888
    [No Abstract]   [Full Text] [Related]  

  • 53. [Isoniazid content of lungs in patients with pulmonary tuberculosis depending on the method of its administration as part of a comprehensive preoperative preparation].
    Strelis AK; Blinov VIu; Gubina NA
    Klin Khir (1962); 1992; (3):55-7. PubMed ID: 1619872
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Treatment of patients with caseous tuberculosis of the lungs with individual maximally tolerated doses of Tubazid].
    Bondarev IM; Tarasova EF; Noskova GP; Oblogina VV; Kanevskaia SS
    Probl Tuberk; 1972; 50(8):8-12. PubMed ID: 4626693
    [No Abstract]   [Full Text] [Related]  

  • 55. Oral solid lipid nanoparticle-based antitubercular chemotherapy.
    Pandey R; Sharma S; Khuller GK
    Tuberculosis (Edinb); 2005; 85(5-6):415-20. PubMed ID: 16256437
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Interrupted treatment with streptomycin and tubazid of patients with pulmonary tuberculosis].
    Ginzburg EA; Levtonova EV; Kaliamova RF; Shilova MV; Samarin MS
    Vrach Delo; 1973 Feb; 2():66-9. PubMed ID: 4722335
    [No Abstract]   [Full Text] [Related]  

  • 57. [Immediate results of intravenous chemotherapy of pulmonary tuberculosis in children and adolescents].
    Khruleva TS; Dimakova RN; Paporish SD
    Probl Tuberk; 1971; 49(4):20-4. PubMed ID: 5316446
    [No Abstract]   [Full Text] [Related]  

  • 58. [Value of ethivanamide combined with isonicotinic acid hydrazine in the intermittent treatment of pulmonary tuberculosis].
    Krawczyk Z; Ratajek M; Sosnowski W
    Gruzlica; 1975 Oct; 43(10):921-7. PubMed ID: 1181252
    [No Abstract]   [Full Text] [Related]  

  • 59. Clinical effect of rifampicin-ethambutol isoniazid on untreated pulmonary tuberculosis.
    Konno K; Oizumi K; Yamada S; Ogata K; Sato M
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):68-72. PubMed ID: 4649624
    [No Abstract]   [Full Text] [Related]  

  • 60. Pathological and immunological profiles of rat tuberculosis.
    Sugawara I; Yamada H; Mizuno S
    Int J Exp Pathol; 2004 Jun; 85(3):125-34. PubMed ID: 15255966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.